A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-sequence, drug-drug interaction study in healthy male and
female subjects. There is no formal research hypothesis to be statistically tested. It is
expected that coadministration of BMS-986020 with montelukast, flurbiprofen, and digoxin may
increase the exposure of montelukast, flurbiprofen, and digoxin.